Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Role of microglia in CNS autoimmunity.
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma.
Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study.
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod for Primary Progressive MS
Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis.
Postpartum complicated by transverse myelitis.
Afferent visual pathways in multiple sclerosis: a review.
Aquaporins: important but elusive drug targets.
Olfactory dysfunction in multiple sclerosis.
The pathology of multiple sclerosis.
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.
Viability of autoantibody-targets: How to tackle pathogenetic heterogeneity as an obstacle for treatment of multiple sclerosis.
Network meta-analysis models to account for variability in treatment definitions: application to dose effects.
Clinical and pathological effects of intrathecal injection of mesenchymal stem cell-derived neural progenitors in an experimental model of multiple sclerosis.
Demyelinating disease in SLE: Is it multiple sclerosis or lupus?
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Amyloid fibrils composed of hexameric peptides attenuate neuroinflammation.
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Effect of Estrogen on Th1, Th2 and Th17 Cytokine Production by Proteolipid Protein and PHA Activated Peripheral Blood Mononuclear Cells Isolated from Multiple Sclerosis Patients.
Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women.
Surveillance and medical therapy following endovascular treatment of chronic cerebrospinal venous insufficiency.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Pages
« first
‹ previous
…
237
238
239
240
241
242
243
244
245
…
next ›
last »